HAOHAI BIOTEC (06826) announced that the company received a notification letter from Mr. Lou Guoliang regarding the completion of his share reduction plan on May 25, 2026. The stipulated time period for this share reduction plan has now expired. As of May 25, 2026, Mr. Lou Guoliang has cumulatively reduced his holdings in the company by 774,700 shares through centralized bidding. This represents approximately 0.3369% of the company's current total issued share capital of 230 million shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.